Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
L. Puiu, A. Didilescu, O. Fira-Mladinescu, C. Pop, M. Greabu, A. Totan, V. R. Nimigean, C. Didilescu (Baia-Mare, Bucharest, Timisoara, Arad, Craiova, Romania). Possible relationships between sleep apnea syndrome, blood biochemical parameters and cardiovascular risk. Eur Respir J 2010; 36: Suppl. 54, 2261

Member's Comments

No comment yet.

Related content which might interest you: The relationship between some oxidative stress markers and metabolic cardiovascular risk factors in the blood of different stage obstructive sleep apnea persons Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea Year: 2008 Relationship between sleep apnea syndrome, plasma myeloperoxidase levels and cardiovascular risk Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012 Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients Source: Eur Respir J 2006; 28: Suppl. 50, 413s Year: 2006 Impaired glucose tolerance and other cardiovascular risk factors in patients with obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Relationship between obstructive sleep apnea syndrome (OSAS) and obesity, cholesterol disorders, blood pressure, and anatomical alterations Source: Eur Respir J 2006; 28: Suppl. 50, 817s Year: 2006 Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007 Metabolic syndrome in obstructive sleep apnea: prevalence and correlation with metabolic abnormalities Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Metabolic syndrome in obstructive sleep apnea: prevalence and correlation with metabolic abnormalities Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea Year: 2008 Is obstructive sleep apnoea a risk factor for cardiovascular disease? Source: Annual Congress 2005 - Cardiovascular disease and obstructive sleep apnoea: risks and remedy Year: 2005 Nocturnal respiratory failure in moderate sleep apnoea as predictive factor of cardiovascular and metabolic comorbidities Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 The genetic and cardiovascular aspects of obstructive sleep apnoea/hypopnoea syndrome Source: Eur Respir J 2009; 33: 233-236 Year: 2009 Relationship between NT-proBNP level, echocardiographic parameters and cardiovascular diseases in patients with obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012 The effects of obstructive sleep apnea syndrome on cognitive and cardiovascular functioning in children with obesity Source: Annual Congress 2012 - Sleep monitoring, lung function and inflammation in childhood Year: 2012 Understanding the pathophysiological mechanisms of cardiometabolic complications in obstructive sleep apnoea: towards personalised treatment approaches Source: Eur Respir J, 56 (2) 1902295; 10.1183/13993003.02295-2019 Year: 2020 Sleep apnoea and hypoventilation syndromes - cardiometabolic consequences Source: International Congress 2018 – PG7 Sleep-disordered breathing - diagnosis and therapy Year: 2018 Influence of genetic ancestry on the risk of obstructive sleep apnoea syndrome Source: Eur Respir J 2010; 36: 834-841 Year: 2010 Menopause and cardiovascular risk factors in sleep apnea Source: Eur Respir J 2006; 28: Suppl. 50, 200s Year: 2006 Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment Source: Eur Respir J 2002; 20: 1511-1518 Year: 2002 Molecular mechanisms underlying metabolic comorbidities in patients with obstructive sleep apnoea Source: Sleep and Breathing Conference 2021 Year: 2021